Jin Medical International Ltd. (NASDAQ:ZJYL – Get Free Report) crossed above its fifty day moving average during trading on Friday. The stock has a fifty day moving average of $2.13 and traded as high as $2.83. Jin Medical International shares last traded at $2.35, with a volume of 3,654,930 shares traded.
Analyst Ratings Changes
Separately, Weiss Ratings reissued a “sell (d)” rating on shares of Jin Medical International in a research report on Friday, September 25th. One analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, the stock currently has an average rating of “Sell”.
Get Our Latest Report on Jin Medical International
Jin Medical International Stock Performance
The company’s 50 day moving average is $2.13 and its 200-day moving average is $2.37. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.70 and a current ratio of 1.95.
Jin Medical International (NASDAQ:ZJYL – Get Free Report) last issued its earnings results on Tuesday, August 4th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business had revenue of $4.46 million during the quarter.
Jin Medical International Company Profile
Jin Medical International Limited is a medical device company focused on the design, manufacture and sale of mobility and daily-living assistance products. Through its operating subsidiaries in China, the company serves customers seeking equipment intended to support mobility, personal care and home or institutional use.
The company’s product portfolio includes manual wheelchairs, electric wheelchairs, walking aids and other related medical and rehabilitation equipment. Its offerings are marketed through domestic and international sales channels, serving distributors, retailers and other customers in China and overseas markets.
Jin Medical International is incorporated in the Cayman Islands and conducts its primary operating activities in China.
Featured Stories
- Five stocks we like better than Jin Medical International
- LyondellBasell’s Dividend Looks Safer, But a New Risk Could Change That
- L3Harris Stock Took a Beating—Is a 20% Rebound Next?
- Starbucks Says Its Turnaround Is Done—The Numbers Make a Strong Case (With 1 Catch)
- 3 Robotics ETFs, 3 Different Ways to Bet on Humanoid Robots
Receive News & Ratings for Jin Medical International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jin Medical International and related companies with MarketBeat.com's FREE daily email newsletter.
